New Lupus Drug Investigational Trial Receives National Institutes of Health Grant
Researchers from Upstate Medical University have received a $7.2 million grant from the National Institutes of Health for a lupus drug Phase 2 clinical trial. The trial involves 20 lupus centers from academic research institutions across the country and will recruit 250 patients.
The trial began enrolling participants on October 1 and is anticipated to last five years, with each trial participant taking part for 13 months. The study will investigate treating lupus with N-acetylcysteine, which the body uses to build antioxidants and are important to repairing cells from damage.
The trial will require study participants to take two pills per day, with each participant being closely monitored and attending a minimum of seven clinic visits where they will donate blood for screening.
The Lupus Foundation of America funded some of the preliminary results that led to this clinical trial and actively supports lupus research through the Gina M. Finzi Memorial Student Summer Fellowship. Learn more about lupus research.